98% min malotilate; High-quality Malotilate; 59937-28-9; malotilate

Jinzhou Jiutai Pharmaceutical Co.,Ltd

Country:China (Mainland)

Year Established: 1951Business type: Manufacturers

Integral:

1. 98% min malotilate
The information of 98% min malotilate is offered by Jinzhou Jiutai Pharmaceutical Co.,Ltd.
CAS NO.: 59937-28-9
Molecular formula: C₁₂H₁₆O₄S₂Assay: Min 98%
Model Number: CP/BP/USP/EP
Description: Malotilate is used in the treatment of ALD because it inhibits CYP2E1 induced by alcohol
98% min malotilate Structural formula:

2. High-quality Malotilate
High-quality Malotilate is a liver protein metabolism, improved compound. High-quality Malotilate is used in the treatment of liver disease and Malotilate can activate the liver, inhibit the progress of liver fibrosis. High-quality Malotilate is also applicable to chronic hepatitis and cirrhosis and late period of compensatory cirrhosis have caused by schistosomiasis hypoalbuminemia, etc.

Jinzhou jiutai pharmaceutical Co., Ltd is the comprehensive pharmaceutical enterprise which has more than 60 years manufacturing history. It was set up in 1951, which is one of the main pharmaceutical enterprises in Liaoning province. It was honored as provincial advanced enterprise、civilized enterprise. The trademark “JiuTai” was also elected as “Chinese well-know trademark” by the state administration for industry & commerce. The company covers an area of 58000m2 and the total assets amounts to 40.98 million yuan, the group has 620 staff members，among them the engineering technical personnel are 310. There are 4 workshops, one research institute, also the holding company for liaoning medical materials co., ltd and Jinzhou XinTaiji fine chemical Co., Ltd. The product structure is reasonable as well as economy runs well. Company has advanced production technology, mature process route and complete system for quality inspection and control, quality is stable and reliable. Over the years, our company always insist on market-oriented, taking the road of science and technology enterprises, increasing research funding, also successfully developed a series of chlorhexidine bulk drugs、National Category II New Drug--- omeprazole, pantoprazole sodium bulk drugs and their formulations , metronidazole and furazolidone suppositories, sanwei hemorrhoids suppository and other dozens of new product, which has six new drugs filled domestic blank. Four types of product system are chlorhexidine-based disinfection materials, gynecology suppositories, anti-peptic ulcer drugs, antipyretic analgesics respectively. Since 2002, company invested tens of millions, jointly developed National category new drug with Shenyang Pharmaceutical University, now Phase III of clinical trial has finished, and has obtained patent authorization of U.S., Russia, China and the EU. With the sustained business conception of integrity-based, mutual development, our permanent principle that contracts are honored and commercial integrity is maintained. In the field of business, the company has streamlined sales team, stable marketing network, product sales throughout the country, and some of products have been exported to Europe and America. Jinzhou jiutai pharmaceutical co, ltd sincerely welcome colleagues in the medical industry at home and abroad to cooperate with us.